Stay updated on Pembrolizumab for Desmoplastic Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page
- Check6 days agoChange DetectedNew update timestamps were added and older ones removed, reflecting the latest revision history of the study record.SummaryDifference0.1%

- Check13 days agoChange DetectedThree new study sites were added (CommonSpirit Saint Joseph Hospital Bardstown; CommonSpirit Saint Joseph Medical Center East Lexington; CommonSpirit Saint Joseph Hospital London), and three existing sites were removed (Flaget Memorial Hospital; Saint Joseph Hospital East; Saint Joseph London). The page includes a new revision tag (v3.6.3).SummaryDifference0.1%

- Check20 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2 on the page, reflecting a software/layout update. This change does not modify the study content or the information presented about the trial.SummaryDifference0.0%

- Check27 days agoChange DetectedCreighton University Medical Center in Omaha was removed from the study site list and the total number of locations decreased from 281 to 280. This change reflects updated site availability for the trial.SummaryDifference0.1%

- Check35 days agoChange DetectedRecruitment status updated to 'No longer looking for participants'. The page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment label, while removing the older 'Intervention / Treatment' label and the previous revision note 'Revision: v3.5.5' and adding 'Revision: v3.6.0'.SummaryDifference0.1%

- Check42 days agoChange DetectedNew participating sites were added (CommonSpirit Saint Anthony Hospital Cancer Center; Saint Joseph Medical Center Hematology and Oncology - Silverdale) and existing sites (Saint Anthony Hospital; Saint Michael Cancer Center) were removed. The study now includes a Sample Collection procedure and the documentation updated to Revision: v3.5.5 with dates 2026-06-01 and 2027-05-15.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Desmoplastic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.